Author

Kirill Miachin

Washington University in St. LouisORCID 0000-0003-3634-457XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Angela C. HirbeiD· 1 shared Benjamin A. GarciaiD· 1 shared Brian N. FinckiD· 1 shared Cynthia HorthiD· 1 shared Eric BarekeiD· 1 shared Jacek MajewskiiD· 1 shared Jerry R. ColcaiD· 1 shared Jin‐Hui HoriD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angela C. HirbeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 5, 2025

Integrated Proteomic and Epigenomic Analysis Reveals IGF2 as a Vulnerability in PRC2-Deficient Malignant Peripheral Nerve Sheath Tumors

Joanna K. Lempiäinen, Kirill Miachin, Xingyu Liu…·Benjamin A. Garcia

This study identifies IGF2 as a therapeutic target in PRC2-deficient MPNSTs by linking PRC2 loss to chromatin remodeling and activation of the IGF2-IGF2BP axis.

1 citation

humanproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintJan 16, 2023

A dual MTOR/NAD+ acting gerotherapy

Jinmei Li, Sandeep Kumar, Kirill Miachin…·Timothy R. Peterson

This paper identifies BIOIO-1001 as a dual mTOR/NAD+ acting gerotherapy that reduces metabolic derangements, inflammation, and fibrosis in NASH and ALS models.

2 citations

humanexperimental assay

𝕏 PostBluesky